Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T36846
(Former ID: TTDI01204)
|
|||||
Target Name |
Mitochondrial function (MF)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Motor neuron disease [ICD-11: 8B60] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Creatine ALS-08 | Drug Info | Phase 3 | Motor neurone disease | [1], [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Creatine ALS-08 | Drug Info | [1], [3] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | The therapeutic role of creatine in Huntington's disease. Pharmacol Ther. 2005 Nov;108(2):193-207. | |||||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4496). | |||||
REF 3 | Creatine for Parkinson's disease. Cochrane Database Syst Rev. 2014 Jun 17;6:CD009646. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.